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prognostic value of the delta 
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The delta neutrophil index (DNI), which reflects the ratio of circulating immature neutrophils, has been 
reported to be highly predictive of mortality in systemic inflammation. We investigated the prognostic 
significance of DNI value for early mortality and neurologic outcomes after pediatric cardiac arrest (CA). 
We retrospectively analyzed the data of eligible patients (<19 years in age). Among 85 patients, 55 
subjects (64.7%) survived and 36 (42.4%) showed good outcomes at 30 days after CA. Cox regression 
analysis revealed that the DNI values immediately after the return of spontaneous circulation, at 24 
hours and 48 hours after CA, were related to an increased risk for death within 30 days after CA (P < 
0.001). A DNI value of higher than 3.3% at 24 hours could significantly predict both 30-day mortality 
(hazard ratio: 11.8; P < 0.001) and neurologic outcomes (odds ratio: 8.04; P = 0.003). The C statistic for 
multivariable prediction models for 30-day mortality (incorporating DNI at 24 hours, compression time, 
and serum sodium level) was 0.799, and the area under the receiver operating characteristic curve of 
DNI at 24 hours for poor neurologic outcome was 0.871. Higher DNI was independently associated with 
30-day mortality and poor neurologic outcomes after pediatric CA.
Cardiac arrest (CA) is a life-threatening condition that results in whole-body ischemia-reperfusion syndrome1,2. 
Despite recent advances in treatment strategies, mortality rates after CA in children still range from 35% to 62%;2–6  
furthermore, about 25% to 84% of children survive to discharge but with poor functional outcomes6–9. Since 
children have greater life expectancy compared to adults, they also have the potential to live long with sequelae 
after ischemic injury10.
Early and precise outcome prediction after CA is mandatory for close monitoring, proper treatment plan-
ning, and family support2. Pupillary reflex, electroencephalographic data and several brain specific biomarkers 
have previously been suggested to be capable of predicting neurologic prognosis after CA in both adults and 
children11–14. However, physical examination could be imprecise due to sedatives or paralytics administered after 
CA11,15, and no single parameter has yet been identified as having advantages over others2,11. The combination of 
multiple biomarkers with clinical parameters was reported to be highly predictive of survival and neurological 
outcomes in adult out-of-hospital cardiac arrest (OHCA)16, but biomarkers usually require specialized laboratory 
equipment for assay and therefore cannot be routinely measured in a typical hospital setting11,14,16.
The delta neutrophil index (DNI) reflects the proportion of circulating immature neutrophils. DNI can easily 
and quickly be obtained from the complete blood count (CBC) by a specific automated blood cell analyzer17,18. 
Several studies have demonstrated that DNI could predict severity in various systemic inflammation statuses 
in adults such as sepsis, vasculitis, upper gastrointestinal bleeding, ST-elevation myocardial infarction, and 
OHCA17–22. However, studies assessing the prognostic value of DNI in pediatric CA still remain limited. The 
aim of this study was to assess the clinical usefulness of DNI as a prognostic marker of short-term mortality and 
neurologic outcomes after CA in pediatric patients.
Results
Patient enrolment and characteristics. Of the 209 patients with CA identified during the study period, 
a total of 123 (58.9%) patients survived at least 24 hours after ROSC (return of spontaneous circulation), while 
86 died in the first 24 hours. We excluded 38 patients due to receiving cardiopulmonary resuscitation (CPR) for 
less than 2 minutes (n = 19), having no available DNI value (n = 18), and loss to follow-up (n = 1) (Fig. 1). The 
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remaining 85 eligible patients were divided according to their mortality and neurologic outcomes at 30 days 
after CA. Fifty-five of the 85 subjects (64.7%) survived, and 36 (42.4%) had good neurologic outcomes (PCPC; 
Pediatric Cerebral Performance Category score = 1–3) at 30 days after CA (Table 1). The baseline clinical charac-
teristics stratified by outcomes are shown in Table 1.
Most of the patients had one or more underlying diseases (92.9%). Among them, 12 (14.1%) patients had 
underlying hemato-oncologic diseases, and all of the malignancy patients had at least more than three chemo-
therapy with or without hematopoietic stem cell transplantation. Their DNI values before CA (sampling within 
48 hours before CA) were mostly 0 (Supplementary Table S1). About 30% of the patients had pre-existing neuro-
logical co-morbidities (29.4%) (Supplementary Table S2). Major etiology of CA was respiratory etiology (52.9%). 
Most cases of respiratory etiology were due to airway obstruction (68.9%, e.g. T-tube displacement/obstruction, 
laryngospasm, bronchial asthma) (Supplementary Table S3).
Modes23 and causes24 of deaths were divided into five categories (Supplementary Tables S4 and S5). The major-
ity of deaths occurred in unstable patients with progressive, refractory hemodynamic shock, and most patients 
died from non-escalation of inotropics or failed resuscitation. Withdrawal of support occurred in one patient who 
had discontinued ECMO due to intractable multi-organ failure. Two patients who were applied ECMO received 
heart transplantation, and no one switched to permanent assist devices.
DNI level and short-term mortality. There were significant differences in DNI values at 0 hour (imme-
diately after ROSC), 24 hours, and 48 hours after CA and in the peak value between survival and non-survival 
groups in terms of 30-day mortality (Table 2). The linear-mixed model showed that DNI values were significantly 
different between groups over the time according to 30-day survival (group: P < 0.001, time: P = 0.017, group × 
time: P = 0.006) (Fig. 2A).
DNI values at 0 hour, 24 hours, and 48 hours and peak DNI value were related to increased risk for death 
within 30 days after CA on univariate Cox regression analyses (Table 3). Along with DNI values, longer time 
of CPR; higher doses of epinephrine (especially more than four doses of epinephrine given during CPR); SB 
administration within 30 days after CA; intubation at the time of arrest; lower white blood cell count, absolute 
neutrophil count, platelet count, and albumin level; and higher lactate, prothrombin time (PT), international nor-
malized ratio (INR), sodium, and C-reactive protein level were significantly associated with short-term mortality 
in univariate Cox analysis (Table 3).
The optimal DNI cut-off values to predict 30-day mortality were 8.8% at 0 hour, 3.3% at 24 hours, 6.5% at 
48 hours, and 19.1% of the peak value. DNI ≥ 3.3% at 24hours showing high sensitivity (89.3%) and moderate 
specificity (66.0%) predicted 30-day mortality after pediatric CA (Table 4). Multivariable analysis showed that if 
DNI at 24 hours was ≥3.3%, then the risk for 30-day mortality increased by 11-fold [hazard ratio (HR): 11.8, 95% 
confidence interval (CI): 2.73–51.01; P < 0.001]. It also indicated that 30-day mortality increased by 7% or 2% for 
a one-unit increase in sodium at 0 hour and the duration of CPR, respectively (HR: 1.07, 95% CI: 1.01–1.14; P = 
0.024 and HR: 1.02, 95% CI: 1.01–1.04; P = 0.003) (Table 3).
Study participants were divided into two groups based on the cut-off values. Kaplan–Meier curves revealed 
the survival curve in each group (Fig. 3). Patients with DNI values higher than the respective cut-off values at 0 
hour, 24 hours, and 48 hours and the peak value had significantly shorter survival lengths in log-rank test (at 0 
hour: P = 0.002; at 24 hours, 48 hours and peak value: P < 0.001).
Pediatric cardiac arrest
during the study period  
(< 19 years)
N=209
IHCA  N=184   OHCA N=25
Follow up loss 
N=1 
IHCA  N=1
No DNI lab data
N=18
IHCA N=12
OHCA N=6
Outcome data available
N=85 
IHCA   N=80    OHCA   N=5   
Survival at 30 days
N=55
Good neurologic outcome
N=36
     Poor neurologic outcome
N=49
Death within 30 days
N=30
Died within 24h 
N=86 
IHCA N=72
OHCA N=14
CPR < 2 min 
N=19
IHCA N=19
Figure 1. Flowchart of patient inclusion and exclusion. DNI, delta neutrophil index; CPR, cardiopulmonary 
resuscitation; IHCA, in-hospital cardiac arrest; OHCA, out-of-hospital cardiac arrest.
3Scientific RepoRtS |         (2020) 10:3497  | https://doi.org/10.1038/s41598-020-60126-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Variables Total(N = 85) [n]
30-day mortality
P-value
30-day PCPC score
P-valueSurvival (N = 55) [n] Death (N = 30) [n] Good (N = 36) [n] Poor (N = 49) [n]
Time of arrest 0.757 0.649
   Day 64(75.29) 42(76.36) 22(73.33) 28(77.78) 36(73.47)
   Night 21(24.71) 13(23.64) 8(26.67) 8(22.22) 13(26.53)
Female sex (n,%) 30(35.29) 18(32.73) 12(40) 0.503 12(33.33) 18(36.73) 0.746
Age, years 2(0.8~9.5)[85] 2.5(1.1~7.8)[55] 2(0.2~11.5)[30] 0.982 3.5(1.1~10)[36] 2(0.6~9)[49] 0.637
IHCA/OHCA 0.340 >0.999
   In hospital 80(94.12) 53(96.36) 27(90) 34(94.44) 46(93.88)
   Out of hospital 5(5.88) 2(3.64) 3(10) 2(5.56) 3(6.12)
Initial rhythm (n,%) 0.409 0.332
   Asystole 23(27.06) 12(21.82) 11(36.67) 9(25) 14(28.57)
   PEA 20(23.53) 15(27.27) 5(16.67) 11(30.56) 9(18.37)
   VT/VF 6(7.06) 5(9.09) 1(3.33) 4(11.11) 2(4.08)
   Bradycardia 34(40) 21(38.18) 13(43.33) 11(30.56) 23(46.94)
   Unknown 2(2.35) 2(3.64) 0(0) 1(2.78) 1(2.04)
CPR duration, min 9(4~24)[85] 6(3~14)[55] 18.5(7~40)[30] 0.002* 5(2.5~10)[36] 14(6~30)[49] 0.001*
Total number of doses of epinephrine 2(1~5)[85] 2(0~3)[55] 4(1~8)[30] 0.026* 1.5(0~2.5)[36] 3(1~8)[49] 0.010*
Epinephrine dosing interval, min 3.3(2.8~5)[66] 3.3(2.7~4.3)[41] 4(2.8~5.4)[25] 0.314 3.2(2.5~4.5)[26] 3.5(2.9~5.3)[40] 0.258
Number of doses of epinephrine 
(categorical) 0.011
* 0.018*
   4 or fewer 43(50.59) 32(58.18) 11(36.67) 22(61.11) 21(42.86)
   >4 23(27.06) 9(16.36) 14(46.67) 4(11.11) 19(38.78)
   None 19(22.35) 14(25.45) 5(16.67) 10(27.78) 9(18.37)
Duration of chest compressions 
(categorical), min 0.018
* 0.050
   ≤15 56(65.88) 42(76.36) 14(46.67) 29(80.56) 27(55.1)
   <15 ≤30 16(18.82) 8(14.55) 8(26.67) 4(11.11) 12(24.49)
   >30 13(15.29) 5(9.09) 8(26.67) 3(8.33) 10(20.41)
Place of arrest 0.454 0.294
   Emergency department 6(7.06) 5(9.09) 1(3.33) 3(8.33) 3(6.12)
   General ward 19(22.35) 11(20) 8(26.67) 5(13.89) 14(28.57)
   Intensive care unit 45(52.94) 29(52.73) 16(53.33) 19(52.78) 26(53.06)
   Operating room 8(9.41) 7(12.73) 1(3.33) 6(16.67) 2(4.08)
   OPD or other clinics 2(2.35) 1(1.82) 1(3.33) 1(2.78) 1(2.04)
   Home or non-clinical location 5(5.88) 2(3.64) 3(10) 2(5.56) 3(6.12)
Open compression 2(2.35) 1(1.82) 1(3.33) >0.999 1(2.78) 1(2.04) >0.999
ECMO application 19(22.35) 10(18.18) 9(30) 0.211 4(11.11) 15(30.61) 0.033*
Intubation during CPR 28(32.94) 16(29.09) 12(40) 0.307 9(25) 19(38.78) 0.182
Intubation present at the time of arrest 29(34.12) 15(27.27) 14(46.67) 0.072 9(25) 20(40.82) 0.129
Etiology 0.221 0.677
   Respiratory 45(52.94) 34(61.82) 11(36.67) 21(58.33) 24(48.98)
   Cardiac 16(18.82) 8(14.55) 8(26.67) 7(19.44) 9(18.37)
   Sepsis 6(7.06) 3(5.45) 3(10) 1(2.78) 5(10.2)
   Others 12(14.12) 7(12.73) 5(16.67) 4(11.11) 8(16.33)
   Unknown 6(7.06) 3(5.45) 3(10) 3(8.33) 3(6.12)
Underlying diseases
   Pulmonary disease 27(31.76) 17(30.91) 10(33.33) 0.819 11(30.56) 16(32.65) 0.837
   Neurologic disease 25(29.41) 18(32.73) 7(23.33) 0.364 11(30.56) 14(28.57) 0.843
   Cardiologic disease 31(36.47) 18(32.73) 13(43.33) 0.332 14(38.89) 17(34.69) 0.691
   Hemato-oncologic disease 12(14.12) 5(9.09) 7(23.33) 0.103 2(5.56) 10(20.41) 0.052
   Pulmonary hypertension 9(10.59) 8(14.55) 1(3.33) 0.150 6(16.67) 3(6.12) 0.159
   Others 29(34.12) 22(40) 7(23.33) 0.121 16(44.44) 13(26.53) 0.085
   None 6(7.06) 5(9.09) 1(3.33) 0.417 3(8.33) 3(6.12) 0.695
SB administration during 30days after CA 0.012* 0.002*
Administered 56(65.88) 31(56.36) 25(83.33) 17(47.22) 39(79.59)
   Not administered 29(34.12) 24(43.64) 5(16.67) 19(52.78) 10(20.41)
SB administration during CPR 0.164 0.017*
Continued
4Scientific RepoRtS |         (2020) 10:3497  | https://doi.org/10.1038/s41598-020-60126-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
DNI level and survival to discharge. We performed the analysis based on survival to discharge 
(Supplementary Table S6). Among the 85 patients initially included in the current study, the number of subjects 
who survived to discharge was 46 (54.1%). Three patients suffered ≥2 CA during the study period (at least 30 
days apart), and we counted their death or discharge as one event; as a result, three cases were excluded due to 
duplication. Finally, 82 cases were included for further analysis.
Lower DNI values at 24 hours and 48 hours and peak DNI value were associated with survival to discharge 
after CA on univariate Cox regression analyses. If DNI at 48 hours was ≥6.5%, then the risk for survival to 
discharge decreased by 0.37-fold [hazard ratio (HR): 0.37, 95% confidence interval (CI): 0.16-0.9; P = 0.027] 
(Supplementary Table S6).
DNI level and short-term neurologic outcome. The mean DNI values at 24 hours, 48 hours and the 
peak DNl value were also significantly higher with poor neurologic outcomes (defined as PCPC score = 4–6) 
(Table 2). In addition, there were significant differences in DNI value between the good and poor neurologic out-
comes groups, but not according to time (group: P < 0.001, time: P = 0.209, group × time: P = 0.080) (Fig. 2B).
Univariate logistic regression analyses showed higher DNI values at 0 hour, 24 hours, and 48 hours and for 
peak value were significantly associated with increased risks of poor neurologic outcomes (Table 5). Lower pH, 
platelet count, and albumin level, as well as higher PT, INR, and sodium level were also associated with poor 
neurologic outcomes in univariate logistic analysis (Table 5). In addition, the administration of SB during CPR 
and within 30 days after CA were significantly associated with increased risks of poor neurologic outcomes in 
univariate logistic analysis, respectively (Table 5).
The optimal DNI cut-off values to predict poor neurologic outcomes were 8.1% at 0 hour, 3.3% at 24 hours, 
4.3% at 48 hours, and 14.5% of the peak value in our study. DNI > 3.3% at 24 hours showing moderate sensitiv-
ity (70.2%) and moderate specificity (77.4%) predicted poor neurologic outcome after pediatric CA (Table 4). 
Multivariable logistic regression using these cut-off values indicated that a DNI value of >3.3% at 24 hours hold-
ing pH and sodium at 0 hour was associated with an eight-fold (OR: 8.04; 95% CI: 2.06–31.42; P = 0.003) OR for 
poor neurologic outcomes. In addition, as pH at 0 hour decreased, the OR of poor neurologic outcome increased 
significantly (OR: 0.01; 95% CI: < 0.01–0.22; P = 0.006) (Table 5).
We performed further analysis for neurologic outcomes among the survivors after CA. CPR duration, total 
number of doses of epinephrine, and total amount of SB administration during CPR were significantly higher in 
poor neurologic outcome patients (Supplementary Table S7). Mean pH level at 0 hour and median Cr level at 48 
hours were significantly lower in poor neurologic outcome group, and median sodium level at 0 hour was higher 
in poor neurologic outcome group (Supplementary Table S8).
Lower level of Ph at 0 hour and the administration of SB during CPR were significantly associated with poor 
neurologic outcomes in univariate analysis (Supplementary Table S9). In addition, DNI value >4.3% at 48 hours 
and peak DNI value >14.5% during 30 days after CA were also significantly associated with poor neurologic out-
comes [odds ratio (OR), 4.60 and 4.67, respectively]. However, we could not find such correlation in multivariable 
analysis (Supplementary Table S9).
Discussion
In the present study, we demonstrated that DNI could be a significant independent predictor of 30-day mortality 
and neurologic outcomes in children in the early post-resuscitation period. Concretely, a DNI value of higher 
than 3.3% at 24 hours after CA significantly predicted 30-day mortality (HR: 11.8; P < 0.001) and neurologic 
outcomes (OR: 8.04; P = 0.003) in this study group of pediatric patients.
In our study, DNI value was significantly higher in non-survivors than in survivors from the time immedi-
ately after CA to later. After CA, patients experienced “post-cardiac arrest syndrome,” which mimics the physi-
ologic changes consistent with observations of severe sepsis1,25. Ischemia-reperfusion after CA stimulates innate 
immunity, and subsequent cytokine release mediates sterile systemic inflammatory responses and multi-organ 
dysfunction16,25. Previously, Yune et al. reported that DNI values of more than 8.4% immediately after emergency 
Variables Total(N = 85) [n]
30-day mortality
P-value
30-day PCPC score
P-valueSurvival (N = 55) [n] Death (N = 30) [n] Good (N = 36) [n] Poor (N = 49) [n]
   Administered 26(30.59) 14(25.45) 12(40.00) 6(16.67) 20(40.82)
   Not administered 59(69.41) 41(74.55) 18(60.00) 30(83.33) 29(59.18)
SB 0 h, mEq 0(0~6) 0(0~0.2)[55] 0(0~8) 0.193 0(0~0)[36] 0(0~10) 0.019*
SB 24 h, mEq 21(0~160) 8(0~120)[55] 96.4(21~343) 0.001* 0(0~47.5)[36] 84(20~194) 0.001*
SB 48 h, mEq 25(0~172.9) 12(0~120)[55] 167.5(23~467.5) <0.001* 0(0~111.8)[36] 120(20~363) 0.002*
Table 1. Baseline clinical characteristics stratified by outcomes. Data are presented as number (percent) or 
median [IQR] as appropriate. A pediatric cerebral performance category (PCPC) score of 1 to 3 or no change 
in score from prearrest indicates good neurologic outcomes, whereas a PCPC score of 4 to 6 indicates poor 
neurologic outcomes. Day was defined as 7:00 am to 10:59 pm, and night was defined as 11:00 pm to 6:59 am. 
IHCA, in-hospital cardiac arrest; OHCA, out-of-hospital cardiac arrest; PEA, pulseless electrical activity; 
VT/VF, ventricular tachycardia/ventricular fibrillation; OPD, outpatient department; ECMO, extracorporeal 
membrane oxygenation; CPR, cardiopulmonary resuscitation; SB, sodium bicarbonate; CA, cardiac arrest; SB 
0 h, total administered amount of sodium bicarbonate during cardiopulmonary resuscitation; SB 24 h, total 
administered amount of sodium bicarbonate until 24 hours after cardiac arrest; SB 48h, total administered 
amount of sodium bicarbonate until 48 hours after cardiac arrest. *P < 0.05.
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Variables Total(N = 85) [n]
30-day mortality
P-value
30-day PCPC score
P-valueSurvival (N = 55) [n] Death (N = 30) [n] Good (N = 36) [n] Poor (N = 49) [n]
DNI 0 h, % 3.4(0~11.7)[85] 1.4(0~6.9)[55] 9.5(0~16.1)[30] 0.032* 1.5(0~5.6)[36] 6.1(0~13.9)[49] 0.070
DNI 24 h, % 3.6(0~14.5)[78] 1.4(0~4.7)[50] 15.1(6.8~27.7)[28] <0.001* 1(0~3.3)[31] 9.4(2.4~19.3)[47] <0.001*
DNI 48 h, % 4.3(0.4~13.1)[71] 3(0~5.7)[47] 12.6(4.7~28.1)[24] <0.001* 1.3(0~4.3)[29] 8(2.2~21.2)[42] <0.001*
DNI peak, % 16.6(5.9~32.3)[85] 10.6(4.3~17.4)[55] 37.6(19.1~51.3)[30] <0.001* 7.5(3.7~13.1)[36] 21.2(16.4~47.9)[49] <0.001*
WBC 0 h, 103/μL 13.6(7.6~17.5)[84] 14.6(10.1~20.7)[54] 9(6.5~14.8)[30] 0.006* 14.8(10.4~20.5)[36] 10.6(7.3~16)[48] 0.027*
WBC 24 h, 103/μL 11.3(6.9~16.7)[76] 10.4(7.5~16)[48] 12.1(4.7~17.2)[28] 0.944 11(7.2~16.7)[31] 11.3(5.6~16.6)[45] 0.870
WBC 48 h, 103/μL 10.1(6.7~14.3)[69] 10(7.7~14.3)[45] 10.1(5.1~14.9)[24] 0.584 9.7(7.8~13.5)[29] 10.4(6.3~15.7)[40] 0.832
ANC 0 h, 103/μL 9.3(6~14.8)[53] 10.8(7.6~18.4)[37] 6.1(3.8~8.5)[16] 0.005* 11.3(7.7~18.4)[25] 7.1(5.7~11.1)[28] 0.036*
ANC 24 h, 103/μL 8.8(4.7~13)[50] 7.1(4.6~11.4)[36] 9.7(9.1~13.4)[14] 0.230 7.2(4.7~10.6)[23] 9.3(4.6~13.4)[27] 0.514
ANC 48, 103/μL 8.8(5.4~13.2)[42] 8(4.5~12.4)[32] 10(8~18)[10] 0.136 7.6(4.5~11.3)[20] 10(6.8~18)[22] 0.155
Hb 0 h, g/dL 10.4±2.5[84] 10.5±2.6[54] 10.2±2.4[30] 0.576 10.7±2.9[36] 10.1±2.1[48] 0.313
Hb 24 h, g/dL 10.2(9~11.8)[76] 10.2(9~11.5)[48] 10.1(9.4~12.3)[28] 0.234 10.3(9.3~11.8)[31] 10.1(9~11.6)[45] 0.937
Hb 48 h, g/dL 9.8(8.9~11.2)[69] 9.6(8.7~11)[45] 10.7(9.5~11.8)[24] 0.072 9.6(8.9~11.1)[29] 9.9(9~11.2)[40] 0.563
RDW 0 h, % 15.1(13.8~17.3)[84] 15.2(13.6~17.4)[54] 14.9(13.9~17.1)[30] 0.541 15.8(13.4~18)[36] 14.8(13.9~16.4)[48] 0.509
RDW 24 h, % 15.1(14.3~17.2)[76] 15(14.3~17.2)[48] 15.2(14.3~17.1)[28] 0.867 15.8(14.1~18.3)[31] 14.8(14.3~15.9)[45] 0.203
RDW 48 h, % 15.3(14.4~16.4)[69] 15.1(14.1~16.2)[45] 15.6(14.6~17.3)[24] 0.132 15.6(14.1~17.6)[29] 15.2(14.4~16.1)[40] 0.662
Platelets 0 h, 103/μL 175(111.5~337)[84] 248(158~380)[54] 124.5(48~228)[30] 0.003* 248(158.5~379.5)[36] 166(55.5~286.5)[48] 0.049*
Platelets 24 h, 103/μL 126.5(83.5~248)[76] 156(110~308.5)[48] 88.5(63.5~142)[28] <0.001* 155(116~316)[31] 109(71~195)[45] 0.007*
Platelets 48 h, 103/μL 109(80~231)[69] 123(83~256)[45] 95(65~143)[24] 0.023* 124(94~257)[29] 101.5(70.5~149.5)[40] 0.095
CRP 0 h, mg/L 13.7(4.2~72.6)[45] 11.3(2.1~26.8)[29] 49.9(6.6~122.5)[16] 0.043* 9.3(1.4~24)[16] 21.6(6.1~78)[29] 0.115
CRP 24 h, mg/L 40.6(4.4~77.9)[23] 40.6(4.4~77.1)[13] 38(5.2~139.2)[10] 0.598 43.7(4.4~77.9)[9] 35.7(5.2~73.7)[14] 0.975
CRP 48 h, mg/L 68.8±62.1[17] 73.7±70.2[12] 57.1±40.5[5] 0.631 91.1±87.2[7] 53.2±33.6[10] 0.309
PT 0 h, sec 15.6(12.8~21.9)[78] 15.3(12.4~19.6)[52] 17.1(14.4~23)[26] 0.103 19.3±18.4[33] 21.6±22.1[45] 0.001*
PT 24 h, sec 16.4(13.9~22)[58] 15.9(13.7~20.7)[37] 19.3(15.2~22.8)[21] 0.097 16.2±4.8[24] 20.6±7.7[34] 0.046*
PT 48 h, sec 17(13~21.9)[54] 15.1(12.5~19.7)[36] 21.4(18~25.2)[18] 0.007* 14.3(12.5~16.3)[22] 19.1(15.6~23.8)[32] 0.032*
INR 0 h, INR 1.4(1.1~1.9)[78] 1.3(1.1~1.7)[52] 1.5(1.3~2)[26] 0.100 1.3(1.1~1.8)[33] 1.4(1.3~2)[45] 0.079
INR 24 h, INR 1.5(1.2~1.9)[58] 1.4(1.2~1.8)[37] 1.7(1.4~2.1)[21] 0.096 1.3(1.2~1.5)[24] 1.7(1.4~2.1)[34] 0.008*
INR 48 h, INR 1.5(1.2~2)[54] 1.4(1.1~1.8)[36] 1.9(1.6~2.2)[18] 0.005* 1.3(1.1~1.4)[22] 1.7(1.4~2.1)[32] 0.022*
aPTT 0 h, sec 49(34.7~78.6)[75] 45.3(33~77.1)[51] 63.1(36.7~82.7)[24] 0.214 38.2(32~66.7)[32] 53.3(39.4~81.6)[43] 0.057
aPTT 24 h, sec 37.4(31.7~50.5)[58] 37.4(31.8~50.6)[37] 37.4(31.7~46.8)[21] 0.808 36.6(30.9~54.6)[24] 38.1(33.2~46.8)[34] 0.764
aPTT 48 h, sec 38.8(32.3~47.7)[53] 37.6(32~47.7)[35] 41.3(37~54.6)[18] 0.182 37.1(32.1~47.7)[21] 39.7(35.2~49.8)[32] 0.561
pH 0 h 7.2±0.2[74] 7.2±0.2[46] 7.1±0.2[28] 0.069 7.3(7.1~7.4)[29] 7.1(7~7.2)[45] 0.001*
pH 24 h 7.4±0.1[63] 7.4±0.1[39] 7.4±0.1[24] 0.167 7.4(7.4~7.5)[25] 7.4(7.3~7.4)[38] 0.065
pH 48 h 7.4(7.3~7.5)[59] 7.4(7.4~7.5)[38] 7.4(7.3~7.4)[21] 0.154 7.4(7.4~7.5)[24] 7.4(7.3~7.5)[35] 0.046*
Lactate 0 h, mmol/L 10.6±5.6[54] 9.9±5.8[36] 12±4.9[18] 0.201 8.8±6[21] 11.8±5[33] 0.059
Lactate 24 h, mmol/L 2.2(1.3~7.5)[26] 1.6(1.1~2)[15] 8.2(4.1~12.8)[11] 0.001* 1.2(1.1~1.6)[9] 5.7(2~11.3)[17] 0.002*
Lactate 48 h, mmol/L 1.3(0.9~2.8)[19] 1(0.9~1.3)[12] 3(2.4~7.1)[7] <0.001* 1(0.8~1.3)[7] 2.3(1.1~3.1)[12] 0.020*
BUN 0 h, mg/dL 13.9(9.1~24.6)[81] 12.3(8.2~21.1)[51] 17.4(10.5~26.2)[30] 0.116 12.7(8.6~23.7)[32] 14.7(9.7~24.6)[49] 0.632
BUN 24 h, mg/dL 17.8(11.2~26.3)[61] 15.2(9.1~26.3)[37] 19.6(14.5~26.6)[24] 0.065 14(8.3~23.6)[24] 19(12.4~26.9)[37] 0.073
BUN 48 h, mg/dL 14.9(9.1~22.1)[53] 14.4(8.8~22.1)[35] 15.8(12.2~22.7)[18] 0.560 14.9(7.1~25.5)[19] 14.6(9.8~22.1)[34] 0.933
Cr 0 h, mg/dL 0.6(0.3~0.8)[81] 0.5(0.3~0.7)[51] 0.7(0.4~0.9)[30] 0.027* 0.5(0.3~0.7)[32] 0.6(0.4~0.8)[49] 0.392
Cr 24 h, mg/dL 0.7(0.4~0.9)[61] 0.6(0.2~0.8)[37] 0.8(0.7~1.2)[24] 0.019* 0.6(0.2~0.8)[24] 0.7(0.5~1)[37] 0.192
Cr 48 h, mg/dL 0.6(0.2~1.1)[53] 0.6(0.2~0.8)[35] 0.6(0.3~1.4)[18] 0.336 0.6(0.3~1.1)[19] 0.5(0.2~1.1)[34] 0.428
Albumin 0 h, g/dL 3(2.3~3.3)[76] 3.1(2.5~3.6)[47] 2.6(2.2~3)[29] 0.009* 3.1±0.7[29] 2.7±0.7[47] 0.043*
Albumin 24 h, g/dL 3.2±0.5[58] 3.2±0.5[35] 3.2±0.6[23] 0.817 3.2±0.5[23] 3.2±0.6[35] 0.856
Albumin 48 h, g/dL 3.2±0.5[54] 3.2±0.5[36] 3.3±0.6[18] 0.388 3.1±0.5[21] 3.3±0.6[33] 0.246
Glucose 0 h, mg/dL 204(108~296)[75] 210(137~296)[49] 186.5(98~284)[26] 0.473 207(144~296)[30] 191(102~289)[45] 0.559
Glucose 24 h, mg/dL 124(100~160)[69] 128(97~149)[43] 122(104~161)[26] 0.985 131(97~145)[25] 122(102.5~162.5)[44] 0.847
Glucose 48 h, mg/dL 127(111~156)[59] 127(116~170)[38] 127(101~138)[21] 0.087 129(120.5~195.5)[20] 127(104~148)[39] 0.124
Sodium 0 h, mmol/L 140.8±6.9[77] 139.1±6.6[51] 144±6.5[26] 0.003* 139(137~141)[32] 142(139~147)[45] 0.004*
Sodium 24 h, mmol/L 141(139~145)[72] 140.5(137.5~144)[48] 142(141~150)[24] 0.018* 140(137~143)[29] 142(140~148)[43] 0.008*
Sodium 48 h, mmol/L 140(137~143)[64] 139(137~143)[43] 141(138~149)[21] 0.107 139.5±4.5[26] 141.7±7.6[38] 0.145
Table 2. Laboratory findings after cardiac arrest stratified by outcomes. Data are presented as median [IQR] or 
mean ± standard deviation as appropriate. A pediatric cerebral performance category (PCPC) score of 1 to 3 or 
no change in score from prearrest indicates good neurologic outcomes, whereas a PCPC score of 4 to 6 indicates 
poor neurologic outcomes. DNI, delta neutrophil index; 0 h, immediately after return of spontaneous circulation; 
24 h, 24 hours after cardiac arrest; 48h, 48hours after cardiac arrest; Peak DNI, highest DNI value during 30 days 
after cardiac arrest; WBC, white blood cell count; ANC, absolute neutrophil count; Hb, haemoglobin; RDW, red 
cell distribution width; CRP, C-reactive protein; PT, prothrombin time; INR, the international normalized ratio; 
aPTT, activated partial thromboplastin time; BUN, blood urea nitrogen; Cr, creatinine. *P <0.05.
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department (ED) admission (HR: 3.22) and those of more than 12.9% at 24 hours after ED admission (HR: 3.29) 
were associated with 30-day mortality in adult OHCA patients20.
DNI and ischemia-reperfusion injury after cardiac arrest. The DNI indicates the ratio of circulating 
immature granulocytes to total neutrophil count. DNI is calculated by using an automated blood cell analyzer26 
with two separate channels, myeloperoxidase (MPO) channels and nuclear lobularity channels17. By subtracting 
the fraction of mature polymorphonuclear leukocytes from the sum of MPO-reactive cells, it can estimate the 
fraction of immature granulocytes such as metamyelocytes, myeloctyes, and promyelocytes17.
High DNI indicate an increase in circulating immature granulocytes, and it occurs in various acute conditions 
such as acute hematological malignancies, bleeding, and sepsis18. Previous studies have also described DNI as a 
useful marker for diagnosing sepsis and septic shock, predicting positive blood culture and disseminated intra-
vascular coagulation17,18,28. Similar to DNI, the elevated immature/total granulocyte ratio (IG%), referred to as a 
left-shift27, is another index of increasing immature granulocytes. Sauneuf et al. reported that a higher immature/
total granulocyte ratio at ICU admission independently predicted death or poor neurologic outcomes (CPC 3–5) 
in a large prospective cohort of patients after OHCA29.
Post-cardiac arrest syndrome is a second, complex phase after CA1,25. Systemic ischemia/reperfusion is one of 
the key components of this status30. Systemic ischemia/reperfusion induces a whole-body inflammation similar 
to SIRS1,31. Increase in circulating immature granulocytes in early post-CA period has been reported20,29, and it 
is assumed to be due to various mechanisms, such as bone marrow ischemia32, neutrophil paralysis33, endotox-
emia34, and a compensatory response due to depletion of mature neutrophils in bone marrow35.
In this study, we used an automated blood cell analyzer (ADVIA 2120) to determine DNI, which overcomes 
the limitation of manual counting that is strongly correlated with manual immature granulocyte counts17,20. Yune 
et al. used the same ADVIA 2120 analyzer, and demonstrated that DNI were associated with 30-day mortality in 
adult OHCA (cut-off value of 12.9% at 24 hours after ED admission)20.
While most published studies used ADVIA to measure DNI for assessing the proportion of immature granu-
locytes36, the majority of them focused on sepsis or infection-related diseases. Since we could only find one study 
that evaluated the clinical value of DNI as diagnostic or prognostic marker after CA20, more studies on how DNI 
proportionately reflects the ischemic insult after CA should be performed using large cohorts.
In contrast with DNI, our results showed that white blood cell count (WBC) and absolute neutrophil count 
(ANC) at 0 hour were lower in patients who died compared to survivors. A previous study also reported that 
initial blood tests during resuscitation revealed a significantly lower WBC in the sustained ROSC group of adult 
OHCA patients37. In another retrospective single-center study with adult IHCA and OHCA patients who under-
went targeted temperature management for post cardiac arrest syndrome within 6 hours of CA, WBC and median 
ANC were also significantly lower in decedents than in survivors38.
Ischemia/reperfusion after CA activates immunological process, resulting in elevated levels of cytokines, sol-
uble receptors, and endotoxins; and these changes are associated with clinically poor outcomes1,25. In sepsis, the 
overproduction of nitric oxide (NO), chemokines, and cytokines reduces chemotaxis and adhesion interactions 
between neutrophils and the endothelium. Alves-Filho et al. suggest neutrophil paralysis to be characterized 
by the failure of neutrophils to migrate into the site of infection, and inappropriate neutrophil sequestration in 
remote organs39. In post-cardiac arrest syndrome, similar to SIRS1, elevated P- and E-selectin, soluble vascular cell 
adhesion molecule-1, and soluble intercellular molecule-1 were observed after CA25,33. Although the mechanisms 
underlying the decrease in WBC and ANC in contrast to immature granulocytes during early resuscitation period 
are unclear, neutrophil paralysis in post-cardiac arrest syndrome can be a possible explanation; severe ischemia 
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Figure 2. Mean DNI values over time associated with mortality (A) and neurologic outcomes (B) at 30 days 
after cardiac arrest. DNI, delta neutrophil index; 0 h, immediately after return of spontaneous circulation; 24 h, 
24 hours after cardiac arrest; 48 h, 48 hours after cardiac arrest. PCPC, Pediatric Cerebral Performance Category. 
A PCPC score of 1 to 3 or no change in score from prearrest indicates good neurologic outcomes, whereas a 
PCPC score of 4 to 6 indicates poor neurologic outcomes (Fig. 2B).
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Variables HR (95% CI) P-value
Univariate Cox analysis
Compression time, min 1.02 (1.01-1.03) <0.001*
Total number of doses of adrenaline 1.06 (1.02-1.1) 0.002*
Adrenaline number (categorical, two)
   None Reference
   4 or fewer 0.97 (0.34-2.79) 0.951
   >4 3.00 (1.08-8.33) 0.035*
Duration of chest compressions (categorical), min
   ≤15 Reference
   <15 ≤ 30 2.38 (1.00-5.69) 0.050*
   >30 3.29 (1.38-7.85) 0.007*
Intubation present at the time of arrest
   No Reference
   Yes 2.05 (1.00-4.22) 0.050*
SB administration within 30 days after cardiac arrest
   Not administered Reference
   Administered 3.20 (1.22-8.36) 0.018*
WBC 0 h (103/μL) 0.94 (0.89-0.99) 0.014*
ANC 0 h (103/μL) 0.90 (0.82-0.98) 0.018*
Platelet counts 0 h (103/μL) 0.99 (0.99-1.00) 0.011*
Platelet counts 24 h (103/μL) 0.99 (0.99-1.00) 0.002*
CRP 0 h (mg/L) 1.01 (1.00-1.01) 0.012*
PT 48h (sec) 1.06 (1.01-1.12) 0.021*
INR 48h (INR) 2.21 (1.2-4.09) 0.012*
Lactate 24 h (mmol/L) 1.45 (1.21-1.75) <0.001*
Lactate 48h (mmol/L) 1.46 (1.13-1.9) 0.005*
Albumin 0 h (g/dL) 0.57 (0.36-0.88) 0.012*
Sodium 0 h (mmol/L) 1.10 (1.04-1.16) 0.001*
Sodium 24 h (mmol/L) 1.09 (1.03-1.16) 0.005*
Sodium 48h (mmol/L) 1.08 (1.01-1.15) 0.028*
DNI 0 h (%) 1.06 (1.03-1.09) <0.001*
DNI 24 h (%) 1.04 (1.02-1.06) <0.001*
DNI 48h (%) 1.07 (1.04-1.09) <0.001*
DNI peak (%) 1.05 (1.03-1.07) <0.001*
DNI 0 h (%)
   <8.8 Reference
   ≥8.8 3.16 (1.53-6.53) 0.002*
DNI 24 h (%)
   <3.3 Reference
   ≥3.3 9.72 (2.93-32.3) <0.001*
DNI 48h (%)
   <6.5 Reference
   ≥6.5 5.13 (2.12-12.43) <0.001*
DNI peak (%)
   <19.1 Reference
   ≥19.1 6.30 (2.69-14.75) <0.001*
Multivariable Cox analysis
   CPR duration 1.02 (1.01-1.04) 0.003*
   Sodium 0 h 1.07 (1.01-1.14) 0.024*
DNI 24 h
   <3.3 Reference
   ≥3.3 11.80 (2.73-51.01) <0.001*
C-index 0.799
Table 3. Cox proportional hazard analysis for 30-day mortality. HR, hazard ratio; CI, confidence interval; SB, 
sodium bicarbonate; WBC, white blood cell; ANC, absolute neutrophil count; CRP, C-reactive protein; PT, 
prothrombin time; INR, international normalized ratio; DNI, delta neutrophil index; 0 h, immediately after 
return of spontaneous circulation; 24 h, 24 hours after cardiac arrest; 48h, 48 hours after cardiac arrest; Peak 
DNI, highest DNI value during 30 days after cardiac arrest; CPR, cardiopulmonary resuscitation *P <0.05.
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may induce more degree of interactions between adhesion molecules and activated neutrophils with subsequently 
more decreased circulating neutrophils20.
In summary, whole-body ischemia/reperfusion after CA results in a status similar to sepsis-like syndrome. 
It also elevates cytokines, the presence of endotoxin in plasma, activation of coagulation pathways, and inhibi-
tion of anticoagulant pathways1,30,40. However, pediatric studies evaluating immune-inflammatory response that 
represents systemic ischemia/reperfusion status after CA are limited in comparison to adult studies41. Therefore, 
data extrapolated from adult studies are currently used for the understanding and management of pediatric 
post-cardiac arrest syndrome30,42.
DNI (cut off value) Sensitivity (95% CI) Specificity (95% CI)
Outcome (30-day mortality)
DNI 0 h (≥8.8%) 56.7(37.4–74.5) 78.2(65.0––88.2)
DNI 24 h (≥3.3%) 89.3(71.8–97.7) 66.0(51.2–78.8)
DNI 48h (≥6.5%) 70.8(48.9–87.4) 78.7(64.3–89.3)
DNI peak (≥19.1%) 76.7(57.7–90.1) 78.2(57.7–90.1)
Outcome (30-day poor neurologic outcome)
DNI 0 h (>8.1%) 46.9(32.5–61.7) 83.3(67.2–93.6)
DNI 24 h (>3.3%) 70.2(55.1–82.7) 77.4(58.9–90.4)
DNI 48h (>4.3%) 69.1(52.9–82.4) 82.8(64.2–94.2)
DNI peak (>14.5%) 75.5(61.1–86.7) 80.6(64.0–91.8)
Table 4. Sensitivity and specificity of DNI for the prediction of outcome according to cut-off values. A 
pediatric cerebral performance category (PCPC) score of 1 to 3 or no change in score from prearrest indicates 
good neurologic outcomes, whereas a PCPC score of 4 to 6 indicates poor neurologic outcomes. DNI, delta 
neutrophil index; 0 h, immediately after return of spontaneous circulation; 24 h, 24 hours after cardiac arrest; 
48h, 48 hours after cardiac arrest; Peak DNI, highest DNI value during 30 days after cardiac arrest.
Log rank test P-value = 0.001
HR(95% CI) = 3.16(1.53-6.53) 
Kaplan - Meier Plot
Duration (days)
1.0
0.0
030 15 20 255 10
0.2
0.4
0.6
0.8
S
ur
vi
va
l P
ro
ba
bi
lit
y
DNI_0h < 8.8
DNI_0h ≥ 8.8
A
Log rank test P-value < 0.001
HR(95% CI) = 9.72(2.93-32.3)
P < 0.001P = 0.002
Kaplan - Meier Plot
Duration (days)
1.0
0.0
030 15 20 255 10
0.2
0.4
0.6
0.8
S
ur
vi
va
l P
ro
ba
bi
lit
y
DNI_24h < 3.3
DNI_24h ≥ 3.3
B
Log rank test P-value < 0.001
HR(95% CI) = 5.13(2.12-12.43) 
P < 0.001 
Kaplan - Meier Plot
Duration (days)
1.0
0.0
030 15 20 255 10
0.2
0.4
0.6
0.8
S
ur
vi
va
l P
ro
ba
bi
lit
y
DNI_48h < 6.5
DNI_48h ≥ 6.5
C
Log rank test P-value < 0.001
HR(95% CI) = 6.3(2.69-14.75)
P < 0.001
Kaplan - Meier Plot
Duration (days)
1.0
0.0
030 15 20 255 10
0.2
0.4
0.6
0.8
S
ur
vi
va
l P
ro
ba
bi
lit
y
D
DNI_Peak < 19.1
DNI_Peak ≥ 19.1
Figure 3. DNI as a predictor of 30-day mortality after cardiac arrest. Higher DNI values at immediately after 
return of spontaneous circulation (A), 24 hours (B), and 48 hours (C) after cardiac arrest and the peak value 
(highest DNI value over 30 days after cardiac arrest) were significantly associated with predicted increases in 30-
day mortality risk among pediatric patients with cardiac arrest.
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In our study, patients who had higher values than the cut-off for DNI at each time point showed significantly 
shorter survival times in Kaplan–Meier curves. Sol et al. reported that DNI at the time of pediatric intensive 
care unit (ICU) admission was associated with disease severity and mortality, with the cut-off value to predict 
Variables OR (95% CI) P-value
Univariate logistic analysis
Compression time, min 1.03 (1.00-1.06) 0.037*
Adrenaline number (categorical, two)
   None Reference
   4 or fewer 1.06 (0.36-3.13) 0.915
   >4 5.28 (1.30-21.5) 0.020*
ECMO application
   No Reference
   Yes 3.53 (1.06-11.76) 0.040*
SB administration within 30 days after cardiac arrest
   Not administered Reference
   Administered 4.36 (1.68-11.32) 0.003*
SB administration during CPR
   Not administered Reference
   Administered 3.45 (1.21-9.81) 0.020*
Platelet counts 24 h (103/μL) 0.99 (0.99-1.00) 0.022*
PT 24 h (sec) 1.14 (1.02-1.28) 0.026*
INR 24 h (INR) 5.17 (1.31-20.47) 0.019*
INR 48h (INR) 3.94 (1.13-13.81) 0.032*
pH 0 h 0.01 (<0.01-0.19) 0.002*
pH 24 h 0.00 (<0.01-1.07) 0.053
pH 48h <0.01 (<0.01-0.23) 0.019*
Albumin 0 h, g/dL 0.49 (0.25-0.99) 0.048*
Sodium 0 h, mmol/L 1.09 (1.01-1.18) 0.028*
Sodium 24 h, mmol/L 1.14 (1.03-1.27) 0.011*
DNI 0 h (%) 1.08 (1.01-1.15) 0.022*
DNI 24 h (%) 1.09 (1.02-1.15) 0.009*
DNI 48h (%) 1.16 (1.05-1.29) 0.004*
DNI peak (%) 1.09 (1.04-1.14) <0.001*
DNI 0 h (%)
   ≤8.1 Reference
   >8.1 4.42 (1.56-12.52) 0.005*
DNI 24 h (%)
   ≤3.3 Reference
   >3.3 8.08 (2.83-23.06) <0.001*
DNI 48h (%)
   ≤4.3 Reference
   >4.3 10.71 (3.34-34.3) <0.001*
DNI peak (%)
   ≤14.5 Reference
   >14.5 12.77 (4.46-36.54) <0.001*
Multivariable logistic analysis
   PH 0 h 0.01 (<0.01-0.22) 0.006*
   Sodium 0 h 1.06 (0.96-1.16) 0.233
DNI 24 h
   ≤3.3 Reference
   >3.3 8.04 (2.06-31.42) 0.003*
AUC 0.871
Table 5. Logistic regression analysis for 30-day neurologic outcome. OR, odds ratio; CI, confidence interval; 
AUC, area under the curve; ECMO, extracorporeal membrane oxygenation; SB, sodium bicarbonate; CPR, 
cardiopulmonary resuscitation; PT, prothrombin time; INR, the international normalized ratio; DNI, delta 
neutrophil index; 0 h, immediately after return of spontaneous circulation; 24 h, 24 hours after cardiac arrest; 
48h, 48 hours after cardiac arrest; Peak DNI, highest DNI value during 30 days after cardiac arrest. *P < 0.05.
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mortality being 4.95%43. The cut-off value of DNI at 24 hours for predicting 30-day mortality in our study was 
similar to the results from the aforementioned pediatric ICU patients.
Nevertheless, the cut-off value at 24 hours in our research was much lower than that of adult OHCA patients 
(3.3% vs. 12.9%). This discrepancy may be attributed to the differences among enrolled patients. Our subjects 
were mostly pediatric in-hospital CA (IHCA) patients. Compared to OHCA, IHCA patients tend to have a 
lower risk of ischemic damage due to the early recognition of CA and administration of high-quality CPR44,45. 
Consequently, the lower cut-off value of DNI in our study may reflect the lower degree of ischemic insult. 
However, there has been no research about the relationship between the degree of ischemia and DNI in pediatric 
patients. Therefore, further research is required demonstrate how inflammatory response is reflected by DNI and 
how it differs and between adults and children in post-cardiac arrest status.
Until now, DNI has been primarily known as a useful diagnostic and prognostic biomarker in bacteraemia 
and sepsis patients. Park et al. reported that a DNI value of more than 6.5% was a useful laboratory marker for 
differentiating severe sepsis and septic shock in adult ICU patients18. Hence, the DNI values in patients whose CA 
aetiology was presumed to be sepsis might be high before arrest, and also affect the association between DNI level 
and outcomes. Nevertheless, in our study, the mean DNI value was not different between sepsis-associated and 
other aetiology groups at each time point (Supplementary Table S10).
Furthermore, other infectious diseases caused respiratory failure (e.g. pneumonia) may likely influence circu-
lating leukocytes; however, DNI usually rises in more severe infections, such as sepsis or severe systemic inflam-
matory status18,46. For example, previous studies have shown that DNI could be useful for distinguishing between 
various infectious conditions, such as APN from lower UTI (cut-off value, >1.3%)47, pulmonary tuberculosis 
from community acquired pneumonia (CAP) (cut-off value, ≤1.0%)48, and low-grade CAP from upper respira-
tory infection (cut-off value, >1.7%)49. However, their cut-off values were much lower than for those for sepsis 
(cut-off value, > 6.5%)18, bacteremia (cut-off value, 4.4%)46 or prognostic cut-off value of adult OHCA (cut-off 
value, >8.4%)20 with our result (cut-off value, 3.3%).
Furthermore, CRP at 0 hour can be raised due to a severe infection, but it also can be raised in the days follow-
ing resuscitation of CA50,51, reflecting a systemic inflammatory response. Previous studies have shown that PCT 
and CRP increase after adult CA, but neither PCT nor CRP level was associated with infection52–55.
In the present study, most cases of respiratory etiology were due to airway obstruction (68.9%, e.g. T-tube 
displacement/obstruction, laryngospasm, bronchial asthma). Therefore, the higher CRP at 0 hour in patients 
who died within 30 days may not be due to infectious cause, but rather due to their severe systemic inflammatory 
response.
Underlying diseases. Another factor that might influence the circulating immature granulocytes was 
underlying hematologic malignancies. In our study, most patients with hematologic malignancies had at least 
more than three chemotherapy and/or hematopoietic stem cell transplantation. Furthermore, DNI value 
before CA (sampling within 48 hours before CA) were mostly 0. Therefore, we assumed that DNI could be 
used to evaluate of the severity of ischemic insult by reflecting the systemic inflammatory status arising from 
ischemic-reperfusion during post-cardiac arrest status. Unfortunately, the number of samples that were taken 
within 48 hours before CA was so small that we could not perform sub-group analysis.
Other prognostic factors. Along with DNI value, a longer duration of CPR and higher sodium at 0 hour 
also showed a significant association with mortality in our multivariable logistic regression model. Longer dura-
tion of compression has been shown to be associated with decreased survival in both pediatric IHCA and OHCA 
patients4,8. In our study, CPR duration was also significantly shorter in survivors. Furthermore, CPR lasting more 
than 30 minutes was significantly associated with 30-day mortality in univariate analysis.
Makino et al. found that 105 adult OHCA patients who were admitted to the ED had no difference in sodium 
level compared to control patients56. Separately, Shin et al.57 reported that, among the initial blood laboratory 
parameters present during CPR of adult OHCA patients, sodium level showed no significant difference between 
survival and non-survival groups. In comparison, higher sodium level was associated with mortality after pedi-
atric CA in our study.
In fact, the sodium level might have a relationship to the SB administered. SB administration has been consid-
ered a treatment option for severe metabolic acidosis in CA. The use of SB during a CA is also known to be asso-
ciated with increased mortality8, but it remains controversial with regard to pediatric patients58. In our study, the 
sodium level was significantly higher at 0 hour and 24 hours in the death group. However, the total administered 
amount of SB was not significantly different at 0 hour, but was significantly higher at 24 hours and 48 hours in the 
death group. Only the administration of SB within 30 days after CA was significantly associated with the 30-days 
mortality in the univariate cox analysis.
So far, to the best of our knowledge, there has been no specific study that investigated the association between 
sodium level and prognosis after CA. Therefore, future studies are needed to specify and confirm the relationship 
between serum sodium level and outcomes after CA.
DNI value and neurologic outcomes. In our study, DNI was significantly higher in cases of poor neuro-
logic outcome at each time point. The association between DNI and neurologic outcome in various conditions, 
including early post-resuscitation status, has rarely been studied, although one single-center retrospective adult 
OHCA study showed that DNI values of more than 8.4% at ED admission (HR: 2.718; P < 0.001) and those of 
more than 10.5% at 24 hours after ED admission (HR: 1.709; P = 0.02) were associated with poor neurologic 
outcomes for OHCA survivors20.
The cut-off level of DNI was almost similar to that in our study in the very early stage (8.4% vs. 8.1%) after CA; 
however, it was still higher than our result at 24 hours after CA (10.5% vs. 3.3%). As mentioned above, these findings 
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may be due to not only the difference between enrolled patients (OHCA vs. IHCA), but also due to the neuronal 
vulnerability of children to hypoxic-ischemic insult59. Children have increased cerebral blood flow and higher meta-
bolic needs as compared to adults, and they undergo neuronal maturation and synaptogenesis at the time of insult42. 
Therefore, lower DNI, which may reflect lower degree of inflammatory status (ischemia) in the early ROSC status, 
may lead to poorer neurologic outcomes in children. However, this phenomenon needs to be studied further.
There have been discrepant results regarding the correlation between pH and neurologic outcomes in CA. In 
a recent cohort study of pediatric IHCA patients, those with poor neurologic outcomes showed lower pH levels 
according to the PCPC scale14. Similarly, in our study, lower pH at 0 hour was independently associated with 
short-term poor neurologic outcomes. However, the other report involving pediatric OHCA patients showed that 
pH level was not related to neurological recovery based on the Vineland Adaptive Behavior Scale, Second Edition 
(VABS-II) score60. The research protocols, such as cohort design, outcome assessment methods, and place of CA, 
could contribute to or account for these differences.
DNI can be determined with a CBC without adding costs or time. Moreover, DNI could be performed inde-
pendently and irrespectively of clinical conditions. Therefore, DNI could be a quick and inexpensive method to 
estimate prognosis in children after CA, especially in the context of limited resources. However, a combination of 
other prognostic parameters might increase outcome prediction, so clinicians should consider multiple factors 
when predicting outcomes in infants and children after CA2,6,14,60,61.
Limiations
Our study had several limitations. First, this was a retrospective study performed at a single, tertiary hospital. 
Further multicenter studies are required to validate our results. Second, we were not able to assess long-term 
clinical outcomes. Third, we could not compare the superiority between DNI and other known prognostic bio-
markers, such as NSE (neuron-specific enolase) and SB100. Further prospective studies are needed to identify 
the accuracy and usefulness of these prognostic markers in pediatric CA patients. Fourth, we could not evaluate 
the pre-existence of infectious disease, which could affect the DNI value during early post-arrest status. However, 
there were no differences between sepsis-associated aetiology group and the other aetiology group at each time 
point. Therefore, we can assume that sepsis status prior to CA has little effect on DNI values during the early 
post-resuscitation period. We could not analyze the previous level of DNI or CRP level before CA; therefore, even 
if DNI is drawn immediately after CA, it might be influenced by previous infectious condition.
Although DNI can contribute to survival prognostication or neuroprognostication in pediatric CA, 
decision-making for an individual patient by DNI alone can be inappropriate, as it only provides the probabil-
ity for a dichotomous outcome (e.g. death or survival). In addition, DNI has yet to be validated in prospective 
pediatric studies after CA. Currently, no single variable has been found to be sufficiently accurate and reliable for 
prognostication in children after CA. Practitioners should consider multiple factors when predicting outcomes in 
infants and children who achieve ROSC after CA2,30.
In summary, we found that a DNI value during early stage of CA independently predicts not only 30-days 
mortality and survival to discharge, but also neurologic outcome at 30 days after CA in pediatric patients. Since 
DNI can be measured concomitantly with CBC, it can be a rapid and easy method with high sensitivity and 
moderate specificity for predicting mortality after pediatric CA. It may be especially useful in clinical setting with 
limited source. We suggest that pediatric patients with higher DNI values during the early post-resuscitation 
period be carefully monitored, so that proper management could be carried out when necessary, especially if the 
DNI value is higher than 3.3% at 24 hours after CA.
Methods
Study design, population, and setting. This retrospective observational cohort study was performed 
between January 2012 and January 2018 at a single tertiary referral hospital. We reviewed medical records from 
our hospital’s CA registry, investigating all pediatric patients who had achieved ROSC after CPR. We included 
patients who had survived for at least 24 hours after ROSC and received CPR for 2 minutes or more. If patients 
suffered more than one event of CA during 30 days, we only included the first event. If CA occurred at least 30 
days apart, we considered it a separate event. Exclusion criteria were as follows: age older than 19 years, lack of 
laboratory data (less than two serum DNI values), and loss to follow-up. The management of patients with CA 
and post-resuscitation care was performed according to the 2010 and 2015 European Resuscitation Council/
American Heart Association guidelines2,62.
The main study outcomes were 30-day mortality and PCPC score at 30 days after CA63. A PCPC score of 1 to 3 
or no change in score from the time of pre-arrest indicated good neurologic outcomes, whereas a PCPC score of 
4 to 6 indicated poor neurologic outcomes12,64. Additionally, we assigned a PCPC score of 6 to patients who died 
within 30 days after CA20. Follow-up of patients who were discharged within 30 days was conducted by a review 
of subsequent out-patient-department clinic charts or through phone interviews with caregivers. All PCPC scores 
were assigned by chart review. Two reviewers, (SHY) and (JGA), independently scored; and in cases of disagree-
ment, a third reviewer (JAL) was consulted. Assigning investigators were blinded to DNI results before scoring.
This study was approved by the Institutional Review Board of Yonsei University Health System (4-2018-0632), 
and the requirement for consent from the patients was waived.
Data collection. The patient data collected were as follows: demographics, underlying significant comorbid-
ities, aetiology of arrest, presence of endotracheal tube at the time of arrest, intubation during the compression, 
initial arrest rhythm, duration of chest compressions, doses of epinephrine during CPR, epinephrine dosing interval 
(duration of CPR/doses of epinephrine during CPR), administration of SB during CPR and within 30 days after CA, 
total amount of sodium bicarbonate administered during CPR, 24 and 48 hours after CA, use of open-chest cardiac 
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compressions, application of extracorporeal membrane oxygenation at the time of ROSC, time of arrest (day was 
defined as 7:00 am to 10:59 pm and night was defined as 11:00 pm to 6:59 am), and location of arrest7,8,61.
Following ROSC, routine blood sampling was performed in all patients according to our resuscitation proto-
cols. DNI and other laboratory tests were measured immediately after ROSC (0 hour) as well as at 24 hours and 
48 hours after CA. Peak DNI (the highest DNI value over 30 days after CA) was then determined. In most cases, 
samples were collected at a fixed time according to the protocol. However, if sampling was difficult for certain 
patients, several laboratory tests could not go on time along with DNI. Selection of laboratory data was based on 
the presence of DNI test in time.
CBC, including DNI value, was analyzed using an automated blood cell analyzer (ADVIA 2120; Siemens, 
Munich, Germany). DNI value was determined by the following formula: DNI = (neutrophil subfraction + 
eosinophil subfraction measured in the myeloperoxidase channel) − (polymorphonuclear subfraction measured 
in the nuclear lobularity channel)17,18.
Statistical analysis. Continuous variables are presented in the format of mean ± standard deviation or 
median (Q1–Q3), depending on whether the normality assumption was met or not. If the normality assump-
tion was not violated, then an independent two-sample t-test was used to compare outcomes between groups. 
In the case of violation of the normality assumption, comparison was conducted using Mann–Whitney U test. 
Categorical variables were compared by chi-squared test or Fisher’s exact test, as appropriate, and the results were 
reported as a frequency along with the percentage in parenthesis.
Cox proportional hazard regression analysis was conducted to investigate the effects of variables on pre-
dicting 30-day mortality. Multiple Cox proportional hazard regression analysis was performed using a stepwise 
method for variable selection to identify independent prognostic factors. Harrell’s C index value also was listed 
for the assessment of prediction performance, with higher C values indicating good performance on prediction. 
Multicollinearity was checked based on the variable inflation factor (VIF) of each variable included in the model. 
Variables with a VIF of ≥10 were not included in the same model due to multicollinearity.
Contal and O’Quigley’s technique was used to find the optimal cut-off point for time to events data. The opti-
mal cut-off point was determined by maximizing the test statistics of log-rank test. Kaplan–Meier curves were 
constructed according to 30-day mortality.
Logistic regression analysis was performed to identify the significant factors for neurologic outcomes. 
Multivariable logistic regression analysis was performed using a stepwise method for variable selection to deter-
mine if DNI level was independently associated with poor outcomes. Receiver operating characteristic (ROC) 
analyses were performed to examine the performances of DNI levels in predicting poor neurologic outcomes. 
Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) and MedCalc 
Statistical Software version 18.9.1 (MedCalc Software, Ostend, Belgium). P < 0.05 was considered to be statisti-
cally significant.
Data availability
The datasets used and/or analyzed in the current study are available from the corresponding author upon 
reasonable request.
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